img

Global Valacyclovir Oral Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Valacyclovir Oral Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Valacyclovir is used to treat herpes virus infections, including herpes labialis (also known as cold sores), herpes zoster (also known as shingles), and herpes simplex (also known as genital herpes) in adults. It is also used to treat chickenpox and cold sores in children.
Valacyclovir Oral report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Valacyclovir Oral market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Valacyclovir Oral industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Valacyclovir Oral key manufacturers include GSK, Sandoz, Sun Pharmaceutical, Cipla, Mylan, Teva, Zydus Pharmaceuticals, West-Ward Pharmaceuticals and Time Cap Labs, etc. GSK, Sandoz, Sun Pharmaceutical are top 3 players and held % sales share in total in 2022.
Valacyclovir Oral can be divided into 500mg Tablet, 1000mg Tablet, 300mg Tablet and Others, etc. 500mg Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Valacyclovir Oral is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Valacyclovir Oral industry development. In 2022, global % sales of Valacyclovir Oral went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Valacyclovir Oral market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Sandoz
Sun Pharmaceutical
Cipla
Mylan
Teva
Zydus Pharmaceuticals
West-Ward Pharmaceuticals
Time Cap Labs
Wockhardt
Apotex
Aurobindo Pharma
Jubilant Pharma
Lunan Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Tasly
Segment by Type
500mg Tablet
1000mg Tablet
300mg Tablet
Others

Segment by Application


Hospital
Drug Store

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Valacyclovir Oral market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Valacyclovir Oral, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Valacyclovir Oral industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Valacyclovir Oral in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Valacyclovir Oral introduction, etc. Valacyclovir Oral Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Valacyclovir Oral market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Valacyclovir Oral Market Overview
1.1 Valacyclovir Oral Product Overview
1.2 Valacyclovir Oral Market Segment by Type
1.2.1 500mg Tablet
1.2.2 1000mg Tablet
1.2.3 300mg Tablet
1.2.4 Others
1.3 Global Valacyclovir Oral Market Size by Type
1.3.1 Global Valacyclovir Oral Market Size Overview by Type (2018-2029)
1.3.2 Global Valacyclovir Oral Historic Market Size Review by Type (2018-2024)
1.3.3 Global Valacyclovir Oral Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Valacyclovir Oral Sales Breakdown by Type (2018-2024)
1.4.2 Europe Valacyclovir Oral Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Valacyclovir Oral Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Valacyclovir Oral Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Valacyclovir Oral Sales Breakdown by Type (2018-2024)
2 Global Valacyclovir Oral Market Competition by Company
2.1 Global Top Players by Valacyclovir Oral Sales (2018-2024)
2.2 Global Top Players by Valacyclovir Oral Revenue (2018-2024)
2.3 Global Top Players by Valacyclovir Oral Price (2018-2024)
2.4 Global Top Manufacturers Valacyclovir Oral Manufacturing Base Distribution, Sales Area, Product Type
2.5 Valacyclovir Oral Market Competitive Situation and Trends
2.5.1 Valacyclovir Oral Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Valacyclovir Oral Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Valacyclovir Oral as of 2022)
2.7 Date of Key Manufacturers Enter into Valacyclovir Oral Market
2.8 Key Manufacturers Valacyclovir Oral Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Valacyclovir Oral Status and Outlook by Region
3.1 Global Valacyclovir Oral Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Valacyclovir Oral Historic Market Size by Region
3.2.1 Global Valacyclovir Oral Sales in Volume by Region (2018-2024)
3.2.2 Global Valacyclovir Oral Sales in Value by Region (2018-2024)
3.2.3 Global Valacyclovir Oral Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Valacyclovir Oral Forecasted Market Size by Region
3.3.1 Global Valacyclovir Oral Sales in Volume by Region (2024-2029)
3.3.2 Global Valacyclovir Oral Sales in Value by Region (2024-2029)
3.3.3 Global Valacyclovir Oral Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Valacyclovir Oral by Application
4.1 Valacyclovir Oral Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Valacyclovir Oral Market Size by Application
4.2.1 Global Valacyclovir Oral Market Size Overview by Application (2018-2029)
4.2.2 Global Valacyclovir Oral Historic Market Size Review by Application (2018-2024)
4.2.3 Global Valacyclovir Oral Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Valacyclovir Oral Sales Breakdown by Application (2018-2024)
4.3.2 Europe Valacyclovir Oral Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Valacyclovir Oral Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Valacyclovir Oral Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Valacyclovir Oral Sales Breakdown by Application (2018-2024)
5 North America Valacyclovir Oral by Country
5.1 North America Valacyclovir Oral Historic Market Size by Country
5.1.1 North America Valacyclovir Oral Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Valacyclovir Oral Sales in Volume by Country (2018-2024)
5.1.3 North America Valacyclovir Oral Sales in Value by Country (2018-2024)
5.2 North America Valacyclovir Oral Forecasted Market Size by Country
5.2.1 North America Valacyclovir Oral Sales in Volume by Country (2024-2029)
5.2.2 North America Valacyclovir Oral Sales in Value by Country (2024-2029)
6 Europe Valacyclovir Oral by Country
6.1 Europe Valacyclovir Oral Historic Market Size by Country
6.1.1 Europe Valacyclovir Oral Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Valacyclovir Oral Sales in Volume by Country (2018-2024)
6.1.3 Europe Valacyclovir Oral Sales in Value by Country (2018-2024)
6.2 Europe Valacyclovir Oral Forecasted Market Size by Country
6.2.1 Europe Valacyclovir Oral Sales in Volume by Country (2024-2029)
6.2.2 Europe Valacyclovir Oral Sales in Value by Country (2024-2029)
7 Asia-Pacific Valacyclovir Oral by Region
7.1 Asia-Pacific Valacyclovir Oral Historic Market Size by Region
7.1.1 Asia-Pacific Valacyclovir Oral Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Valacyclovir Oral Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Valacyclovir Oral Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Valacyclovir Oral Forecasted Market Size by Region
7.2.1 Asia-Pacific Valacyclovir Oral Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Valacyclovir Oral Sales in Value by Region (2024-2029)
8 Latin America Valacyclovir Oral by Country
8.1 Latin America Valacyclovir Oral Historic Market Size by Country
8.1.1 Latin America Valacyclovir Oral Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Valacyclovir Oral Sales in Volume by Country (2018-2024)
8.1.3 Latin America Valacyclovir Oral Sales in Value by Country (2018-2024)
8.2 Latin America Valacyclovir Oral Forecasted Market Size by Country
8.2.1 Latin America Valacyclovir Oral Sales in Volume by Country (2024-2029)
8.2.2 Latin America Valacyclovir Oral Sales in Value by Country (2024-2029)
9 Middle East and Africa Valacyclovir Oral by Country
9.1 Middle East and Africa Valacyclovir Oral Historic Market Size by Country
9.1.1 Middle East and Africa Valacyclovir Oral Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Valacyclovir Oral Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Valacyclovir Oral Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Valacyclovir Oral Forecasted Market Size by Country
9.2.1 Middle East and Africa Valacyclovir Oral Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Valacyclovir Oral Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Valacyclovir Oral Products Offered
10.1.5 GSK Recent Development
10.2 Sandoz
10.2.1 Sandoz Company Information
10.2.2 Sandoz Introduction and Business Overview
10.2.3 Sandoz Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sandoz Valacyclovir Oral Products Offered
10.2.5 Sandoz Recent Development
10.3 Sun Pharmaceutical
10.3.1 Sun Pharmaceutical Company Information
10.3.2 Sun Pharmaceutical Introduction and Business Overview
10.3.3 Sun Pharmaceutical Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sun Pharmaceutical Valacyclovir Oral Products Offered
10.3.5 Sun Pharmaceutical Recent Development
10.4 Cipla
10.4.1 Cipla Company Information
10.4.2 Cipla Introduction and Business Overview
10.4.3 Cipla Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Cipla Valacyclovir Oral Products Offered
10.4.5 Cipla Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Mylan Valacyclovir Oral Products Offered
10.5.5 Mylan Recent Development
10.6 Teva
10.6.1 Teva Company Information
10.6.2 Teva Introduction and Business Overview
10.6.3 Teva Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Teva Valacyclovir Oral Products Offered
10.6.5 Teva Recent Development
10.7 Zydus Pharmaceuticals
10.7.1 Zydus Pharmaceuticals Company Information
10.7.2 Zydus Pharmaceuticals Introduction and Business Overview
10.7.3 Zydus Pharmaceuticals Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Zydus Pharmaceuticals Valacyclovir Oral Products Offered
10.7.5 Zydus Pharmaceuticals Recent Development
10.8 West-Ward Pharmaceuticals
10.8.1 West-Ward Pharmaceuticals Company Information
10.8.2 West-Ward Pharmaceuticals Introduction and Business Overview
10.8.3 West-Ward Pharmaceuticals Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.8.4 West-Ward Pharmaceuticals Valacyclovir Oral Products Offered
10.8.5 West-Ward Pharmaceuticals Recent Development
10.9 Time Cap Labs
10.9.1 Time Cap Labs Company Information
10.9.2 Time Cap Labs Introduction and Business Overview
10.9.3 Time Cap Labs Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Time Cap Labs Valacyclovir Oral Products Offered
10.9.5 Time Cap Labs Recent Development
10.10 Wockhardt
10.10.1 Wockhardt Company Information
10.10.2 Wockhardt Introduction and Business Overview
10.10.3 Wockhardt Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Wockhardt Valacyclovir Oral Products Offered
10.10.5 Wockhardt Recent Development
10.11 Apotex
10.11.1 Apotex Company Information
10.11.2 Apotex Introduction and Business Overview
10.11.3 Apotex Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Apotex Valacyclovir Oral Products Offered
10.11.5 Apotex Recent Development
10.12 Aurobindo Pharma
10.12.1 Aurobindo Pharma Company Information
10.12.2 Aurobindo Pharma Introduction and Business Overview
10.12.3 Aurobindo Pharma Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Aurobindo Pharma Valacyclovir Oral Products Offered
10.12.5 Aurobindo Pharma Recent Development
10.13 Jubilant Pharma
10.13.1 Jubilant Pharma Company Information
10.13.2 Jubilant Pharma Introduction and Business Overview
10.13.3 Jubilant Pharma Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Jubilant Pharma Valacyclovir Oral Products Offered
10.13.5 Jubilant Pharma Recent Development
10.14 Lunan Pharmaceutical
10.14.1 Lunan Pharmaceutical Company Information
10.14.2 Lunan Pharmaceutical Introduction and Business Overview
10.14.3 Lunan Pharmaceutical Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Lunan Pharmaceutical Valacyclovir Oral Products Offered
10.14.5 Lunan Pharmaceutical Recent Development
10.15 Shandong Luoxin Pharmaceutical Group
10.15.1 Shandong Luoxin Pharmaceutical Group Company Information
10.15.2 Shandong Luoxin Pharmaceutical Group Introduction and Business Overview
10.15.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Products Offered
10.15.5 Shandong Luoxin Pharmaceutical Group Recent Development
10.16 Tasly
10.16.1 Tasly Company Information
10.16.2 Tasly Introduction and Business Overview
10.16.3 Tasly Valacyclovir Oral Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Tasly Valacyclovir Oral Products Offered
10.16.5 Tasly Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Valacyclovir Oral Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Valacyclovir Oral Industrial Chain Analysis
11.4 Valacyclovir Oral Market Dynamics
11.4.1 Valacyclovir Oral Industry Trends
11.4.2 Valacyclovir Oral Market Drivers
11.4.3 Valacyclovir Oral Market Challenges
11.4.4 Valacyclovir Oral Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Valacyclovir Oral Distributors
12.3 Valacyclovir Oral Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 500mg Tablet
Table 2. Major Company of 1000mg Tablet
Table 3. Major Company of 300mg Tablet
Table 4. Major Company of Others
Table 5. Global Valacyclovir Oral Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Valacyclovir Oral Sales by Type (2018-2024) & (K Units)
Table 7. Global Valacyclovir Oral Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Valacyclovir Oral Sales by Type (2018-2024) & (US& Million)
Table 9. Global Valacyclovir Oral Market Share in Value by Type (2018-2024)
Table 10. Global Valacyclovir Oral Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Valacyclovir Oral Sales by Type (2024-2029) & (K Units)
Table 12. Global Valacyclovir Oral Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Valacyclovir Oral Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Valacyclovir Oral Sales Market Share in Value by Type (2024-2029)
Table 15. Global Valacyclovir Oral Price by Type (2024-2029) & (USD/Unit)
Table 16. North America Valacyclovir Oral Sales by Type (2018-2024) & (K Units)
Table 17. North America Valacyclovir Oral Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Valacyclovir Oral Sales (K Units) by Type (2018-2024)
Table 19. Europe Valacyclovir Oral Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Valacyclovir Oral Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Valacyclovir Oral Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Valacyclovir Oral Sales (K Units) by Type (2018-2024)
Table 23. Latin America Valacyclovir Oral Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Valacyclovir Oral Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Valacyclovir Oral Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Valacyclovir Oral Sales by Company (2018-2024) & (K Units)
Table 27. Global Valacyclovir Oral Sales Share by Company (2018-2024)
Table 28. Global Valacyclovir Oral Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Valacyclovir Oral Revenue Share by Company (2018-2024)
Table 30. Global Market Valacyclovir Oral Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Valacyclovir Oral Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Valacyclovir Oral Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Valacyclovir Oral as of 2022)
Table 34. Date of Key Manufacturers Enter into Valacyclovir Oral Market
Table 35. Key Manufacturers Valacyclovir Oral Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Valacyclovir Oral Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Valacyclovir Oral Sales by Region (2018-2024) & (K Units)
Table 39. Global Valacyclovir Oral Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Valacyclovir Oral Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Valacyclovir Oral Sales Market Share in Value by Region (2018-2024)
Table 42. Global Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Valacyclovir Oral Sales by Region (2024-2029) & (K Units)
Table 44. Global Valacyclovir Oral Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Valacyclovir Oral Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Valacyclovir Oral Sales Market Share in Value by Region (2024-2029)
Table 47. Global Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 48. Global Valacyclovir Oral Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Valacyclovir Oral Sales by Application (2018-2024) & (K Units)
Table 50. Global Valacyclovir Oral Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Valacyclovir Oral Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Valacyclovir Oral Sales Market Share in Value by Application (2018-2024)
Table 53. Global Valacyclovir Oral Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Valacyclovir Oral Sales by Application (2024-2029) & (K Units)
Table 55. Global Valacyclovir Oral Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Valacyclovir Oral Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Valacyclovir Oral Sales Market Share in Value by Application (2024-2029)
Table 58. Global Valacyclovir Oral Price by Application (2024-2029) & (USD/Unit)
Table 59. North America Valacyclovir Oral Sales by Application (2018-2024) (K Units)
Table 60. North America Valacyclovir Oral Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Valacyclovir Oral Sales by Application (2018-2024) (K Units)
Table 62. Europe Valacyclovir Oral Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Valacyclovir Oral Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Valacyclovir Oral Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Valacyclovir Oral Sales by Application (2018-2024) (K Units)
Table 66. Latin America Valacyclovir Oral Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Valacyclovir Oral Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Valacyclovir Oral Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Valacyclovir Oral Sales by Country (2018-2024) & (K Units)
Table 70. North America Valacyclovir Oral Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Valacyclovir Oral Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Valacyclovir Oral Sales Market Share in Value by Country (2018-2024)
Table 73. North America Valacyclovir Oral Sales by Country (2024-2029) & (K Units)
Table 74. North America Valacyclovir Oral Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Valacyclovir Oral Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Valacyclovir Oral Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Valacyclovir Oral Sales by Country (2018-2024) & (K Units)
Table 78. Europe Valacyclovir Oral Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Valacyclovir Oral Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Valacyclovir Oral Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Valacyclovir Oral Sales by Country (2024-2029) & (K Units)
Table 82. Europe Valacyclovir Oral Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Valacyclovir Oral Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Valacyclovir Oral Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Valacyclovir Oral Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Valacyclovir Oral Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Valacyclovir Oral Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Valacyclovir Oral Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Valacyclovir Oral Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Valacyclovir Oral Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Valacyclovir Oral Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Valacyclovir Oral Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Valacyclovir Oral Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Valacyclovir Oral Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Valacyclovir Oral Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Valacyclovir Oral Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Valacyclovir Oral Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Valacyclovir Oral Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Valacyclovir Oral Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Valacyclovir Oral Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Valacyclovir Oral Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Valacyclovir Oral Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Valacyclovir Oral Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Valacyclovir Oral Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Valacyclovir Oral Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Valacyclovir Oral Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Valacyclovir Oral Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Valacyclovir Oral Sales Market Share in Value by Country (2024-2029)
Table 109. GSK Company Information
Table 110. GSK Introduction and Business Overview
Table 111. GSK Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. GSK Valacyclovir Oral Product
Table 113. GSK Recent Development
Table 114. Sandoz Company Information
Table 115. Sandoz Introduction and Business Overview
Table 116. Sandoz Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Sandoz Valacyclovir Oral Product
Table 118. Sandoz Recent Development
Table 119. Sun Pharmaceutical Company Information
Table 120. Sun Pharmaceutical Introduction and Business Overview
Table 121. Sun Pharmaceutical Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Sun Pharmaceutical Valacyclovir Oral Product
Table 123. Sun Pharmaceutical Recent Development
Table 124. Cipla Company Information
Table 125. Cipla Introduction and Business Overview
Table 126. Cipla Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Cipla Valacyclovir Oral Product
Table 128. Cipla Recent Development
Table 129. Mylan Company Information
Table 130. Mylan Introduction and Business Overview
Table 131. Mylan Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Mylan Valacyclovir Oral Product
Table 133. Mylan Recent Development
Table 134. Teva Company Information
Table 135. Teva Introduction and Business Overview
Table 136. Teva Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Teva Valacyclovir Oral Product
Table 138. Teva Recent Development
Table 139. Zydus Pharmaceuticals Company Information
Table 140. Zydus Pharmaceuticals Introduction and Business Overview
Table 141. Zydus Pharmaceuticals Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Zydus Pharmaceuticals Valacyclovir Oral Product
Table 143. Zydus Pharmaceuticals Recent Development
Table 144. West-Ward Pharmaceuticals Company Information
Table 145. West-Ward Pharmaceuticals Introduction and Business Overview
Table 146. West-Ward Pharmaceuticals Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. West-Ward Pharmaceuticals Valacyclovir Oral Product
Table 148. West-Ward Pharmaceuticals Recent Development
Table 149. Time Cap Labs Company Information
Table 150. Time Cap Labs Introduction and Business Overview
Table 151. Time Cap Labs Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Time Cap Labs Valacyclovir Oral Product
Table 153. Time Cap Labs Recent Development
Table 154. Wockhardt Company Information
Table 155. Wockhardt Introduction and Business Overview
Table 156. Wockhardt Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Wockhardt Valacyclovir Oral Product
Table 158. Wockhardt Recent Development
Table 159. Apotex Company Information
Table 160. Apotex Introduction and Business Overview
Table 161. Apotex Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Apotex Valacyclovir Oral Product
Table 163. Apotex Recent Development
Table 164. Aurobindo Pharma Company Information
Table 165. Aurobindo Pharma Introduction and Business Overview
Table 166. Aurobindo Pharma Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Aurobindo Pharma Valacyclovir Oral Product
Table 168. Aurobindo Pharma Recent Development
Table 169. Jubilant Pharma Company Information
Table 170. Jubilant Pharma Introduction and Business Overview
Table 171. Jubilant Pharma Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Jubilant Pharma Valacyclovir Oral Product
Table 173. Jubilant Pharma Recent Development
Table 174. Lunan Pharmaceutical Company Information
Table 175. Lunan Pharmaceutical Introduction and Business Overview
Table 176. Lunan Pharmaceutical Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. Lunan Pharmaceutical Valacyclovir Oral Product
Table 178. Lunan Pharmaceutical Recent Development
Table 179. Shandong Luoxin Pharmaceutical Group Company Information
Table 180. Shandong Luoxin Pharmaceutical Group Introduction and Business Overview
Table 181. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 182. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product
Table 183. Shandong Luoxin Pharmaceutical Group Recent Development
Table 184. Tasly Company Information
Table 185. Tasly Introduction and Business Overview
Table 186. Tasly Valacyclovir Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 187. Tasly Valacyclovir Oral Product
Table 188. Tasly Recent Development
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Valacyclovir Oral Market Trends
Table 192. Valacyclovir Oral Market Drivers
Table 193. Valacyclovir Oral Market Challenges
Table 194. Valacyclovir Oral Market Restraints
Table 195. Valacyclovir Oral Distributors List
Table 196. Valacyclovir Oral Downstream Customers
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Valacyclovir Oral Product Picture
Figure 2. Global Valacyclovir Oral Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Valacyclovir Oral Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Valacyclovir Oral Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 500mg Tablet
Figure 6. Global 500mg Tablet Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 1000mg Tablet
Figure 8. Global 1000mg Tablet Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of 300mg Tablet
Figure 10. Global 300mg Tablet Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Valacyclovir Oral Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Valacyclovir Oral Sales Market Share by Type in 2022 & 2029
Figure 15. North America Valacyclovir Oral Sales Market Share in Volume by Type in 2022
Figure 16. North America Valacyclovir Oral Sales Market Share in Value by Type in 2022
Figure 17. Europe Valacyclovir Oral Sales Market Share in Volume by Type in 2022
Figure 18. Europe Valacyclovir Oral Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Valacyclovir Oral Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Valacyclovir Oral Sales Market Share in Value by Type in 2022
Figure 21. Latin America Valacyclovir Oral Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Valacyclovir Oral Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Valacyclovir Oral Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Valacyclovir Oral Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Valacyclovir Oral Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Valacyclovir Oral Revenue in 2022
Figure 27. Valacyclovir Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Drug Store
Figure 31. Global Drug Store Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Valacyclovir Oral Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Valacyclovir Oral Sales Market Share by Application in 2022 & 2029
Figure 34. North America Valacyclovir Oral Sales Market Share in Volume by Application in 2022
Figure 35. North America Valacyclovir Oral Sales Market Share in Value by Application in 2022
Figure 36. Europe Valacyclovir Oral Sales Market Share in Volume by Application in 2022
Figure 37. Europe Valacyclovir Oral Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Valacyclovir Oral Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Valacyclovir Oral Sales Market Share in Value by Application in 2022
Figure 40. Latin America Valacyclovir Oral Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Valacyclovir Oral Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Valacyclovir Oral Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Valacyclovir Oral Manufacturing Cost Structure
Figure 45. Valacyclovir Oral Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries